iBio, Inc. (IBIO)
2.83
+0.14
(+5.20%)
USD |
NASDAQ |
Mar 04, 16:00
2.85
+0.02
(+0.71%)
After-Hours: 20:00
iBio Research and Development Expense (Annual) : 8.312M for June 30, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Bristol Myers Squibb Co. | 9.492B |
| Vor Biopharma, Inc. | 93.31M |
| Recursion Pharmaceuticals, Inc. | 425.27M |
| Senti Biosciences, Inc. | 33.38M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |